PER Percheron Therapeutics Limited
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Around Wednesday 6 October 2027
Estimated 52 weeks after the last AGM. This will update when the company announces its date or lodges its notice of meeting.
Last AGM voting results
Results of the AGM held Wednesday 7 October 2026.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | To Adopt the | 98.76% | 1.24% | carried |
| 2 | Election of Director - Dr James Garner | 99.35% | 0.65% | carried |
| 3 | Approval for issue of Restricted Stock Units to Dr Michael Baker | 97.91% | 2.09% | carried |
| 4 | Ratification of Prior Issue of Adviser Options to Blue Ocean | 98.67% | 1.33% | carried |
| 5 | Ratification of Prior Issue of Joint Lead Manager Options to Blue Ocean and Cygnet Capital | 98.66% | 1.34% | carried |
| 6 | Re-approval of Percheron Therapeutics Employee Share Option Plan | 98.80% | 1.20% | carried |
| 7 | Approval of potential termination benefits under the ESOP | 98.54% | 1.46% | carried |
| 8 | (Special Resolution) | 98.59% | 1.41% | carried |
| 9(a) | Ratification of prior issue of Tranche 1 Placement Shares issued under Listing Rule | 98.61% | 1.39% | carried |
| 9(b) | Ratification of prior issue of Tranche 1 Placement Shares issued under Listing Rule | 98.61% | 1.39% | carried |
| 10 | Approval for issue of Tranche 2 Placement Shares | 98.59% | 1.41% | carried |
| 11 | Approval for issue of Placement Options | 98.59% | 1.41% | carried |
| 12(a) | Approval for issue of Related Party Placement Securities to Dr Michael Baker | 98.59% | 1.41% | carried |
| 12(b) | Approval for issue of Related Party Placement Securities to Mr James Baker | 98.58% | 1.42% | carried |
| 13 | Approval of Issue of Broker Options to Blue Ocean and Cygnet Capital | 98.59% | 1.41% | carried |
The AGM before that (Wednesday 22 October 2025): 14.60% against the remuneration report. Results ↗